62nd ASH Annual Meeting and Exposition: 902. Health Services Research—Malignant Conditions (Lymphoid Disease) II

Oral and Poster Abstracts
Oral

SARS-CoV-2/COVID-19, Leukemia, Coronaviruses, ALL, Adult, AML, survivorship, viral, Diseases, Lymphoma (any), Combinations, Elderly, Therapies, Non-Hodgkin Lymphoma, Pediatric, B-Cell Lymphoma, DLBCL, Infectious Diseases, Lymphoid Malignancies, Study Population, Clinically relevant, Myeloid Malignancies, Quality Improvement

Moderators:

Kelly D Getz, University of Pennsylvania Perelman School of Medicine, The Children's Hospital of Philadelphia and Matthew C. Cheung, MD, MSc, Sunnybrook Odette Cancer Centre

Disclosures:

No relevant conflicts of interest to declare.

1:30 PM

742

Frailty Is Associated with Increased One-Year Mortality in Patients with Newly Diagnosed Diffuse Large-B-Cell Lymphoma: A Population-Based Study

Abi Vijenthira, MD^1,2, Lee Mozessohn, MD^3,4, Chenthila Nagamuthu, MPH⁵^*, Ning Liu⁶^*, Danielle Blunt, MD⁷^*, Shabbir Alibhai, MD, MSc⁸^*, Anca Prica, MD¹ and Matthew C. Cheung, MD, MSc^4,6,9

¹Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada
²Department of Medicine, University of Toronto, Toronto, ON, Canada
³University of Toronto, Toronto, ON, Canada
⁴Sunnybrook Odette Cancer Centre, Toronto, ON, Canada
⁵Cancer Research Program, Institute for Clinical Evaluative Sciences, Toronto, ON, Canada
⁶Institute for Clinical Evaluative Sciences, Toronto, Canada
⁷Royal Adelaide Hospital, Adelaide, SA, Australia
⁸Department of Medicine, University of Toronto & University Health Network, Toronto, ON, Canada
⁹Department of Medicine, University of Toronto, Toronto, Canada

1:45 PM

743

Functional Status and Therapy for Older Patients with Diffuse Large B-Cell Lymphoma (DLBCL): A Population-Based Study

Mengyang Di, MD^1,2, Tamra Keeney, DPT, PhD^3,4^*, Emmanuelle Belanger, PhD^3,4^*, Orestis A. Panagiotou, MD, PhD^3,5^* and Adam J Olszewski, MD⁶

¹Department of Medicine, Rhode Island Hospital, Providence, RI
²Department of Hematology/Oncology, Yale New Haven Hospital, New Haven, CT
³Center for Gerontology and Health Care Research, Brown University School of Public Health, Providence, RI
⁴Department of Health Services, Policy & Practice, Brown University School of Public Health, Providence, RI
⁵Brown University and Lifespan Cancer Institute, Providence, RI
⁶Division of Hematology-Oncology, Rhode Island Hospital, Providence, RI

2:00 PM

744

Pre-Diagnostic and Cancer-Associated Depression and Anxiety Among Patients with Hematologic Malignancies in the United States

Thomas M. Kuczmarski, MD¹^*, Tim Jaung, MS²^*, Claire E. Mancuso, BS²^*, Lizabeth Roemer, PhD³^*, Gregory A. Abel, MD, MPH² and Oreofe O. Odejide, MD, MPH⁴

¹Brigham and Women's Hospital, Boston, MA
²Dana-Farber Cancer Institute, Boston, MA
³University of Massachusetts, Boston, MA
⁴Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA

2:15 PM

745

Outcomes of Adult and Pediatric Patients with Hematologic Malignancies and COVID-19: A Systematic Review and Meta-Analysis of 1847 Patients

Abi Vijenthira, MD^1,2, Inna Gong, MD²^*, Thomas A Fox, BSc, MSc, MRCP³^*, Stephen Booth⁴^*, Gordon Cook, MB ChB, PhD⁵^*, Bruno Fattizzo, MD⁶^*, Fernando Martín Moro⁷^*, Jerome Razanamahery, MD⁸^*, John Riches, MD, PhD^9,10, Jeffrey I. Zwicker, MD¹¹, Rushad Patell, MBBS¹², Marie Christiane Vekemans¹³^*, Lydia Scarfo¹⁴^*, Thomas Chatzikonstantinou¹⁵^*, Halil Yildiz, MD¹⁶^*, Raphael Lattenist, MD¹⁶^*, Ioannis Mantzaris, MD, MS¹⁷, William Wood, MD¹⁸^* and Lisa K. Hicks, MD, MSc^19,20

¹Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada
²Department of Medicine, University of Toronto, Toronto, ON, Canada
³University College London Hospitals NHS Foundation Trust, London, United Kingdom
⁴Churchill Hospital, Oxford, ENG, GBR
⁵Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, United Kingdom
⁶UOC Ematologia, Fondazione IRCCS Ca' Grande Ospedale Maggiore Policlinico and University of Milan, Milano, Milano, Italy
⁷Hematology and Hemotherapy, Hospital Universitario Ramón y Cajal, Madrid, Spain
⁸Besancon University Hospital, Besancon, France
⁹Centre, Barts Cancer Institute, London, United Kingdom
¹⁰The Francis Crick Institute, London, United Kingdom
¹¹Beth Israel Deaconess Medical Center Harvard Medical School, Boston, MA
¹²Beth Israel Deaconess Medical Center, Boston, MA
¹³Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Bruxelles, Belgium
¹⁴Università Vita-Salute San Raffaele and IRCCS Ospedale San Raffaele, Milano, Italy
¹⁵Hematology Department and HCT Unit, George Papanicolaou Hospital, Thessaloniki, GRC
¹⁶Université catholique de Louvain, Louvain-la-Neuve, Belgium
¹⁷Hematology/Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY
¹⁸University of North Carolina at Chapel Hill, Chapel Hill, NC
¹⁹Li Ka Shing Knowledge Institute, University of Toronto, Toronto, ON, Canada
²⁰Division of Hematology/Oncology, St. Michael's Hospital, Toronto, ON, Canada

2:30 PM

746

Treating Acute Leukemia during the COVID-19 Pandemic: A Multicenter Latin American Registry

Roberta Demichelis, MD¹, Martha Alvarado²^*, Jule F Vasquez, MD³, Nancy Delgado⁴^*, Cynthia Gómez⁴^*, Karla Adriana Espinosa, MD⁵^*, Ana Cooke⁶^*, Andrea Milan⁷^*, Andres Gomez-De Leon, MD⁸, Lee-Tsai Yu Ling⁹^*, Daniel Estuardo Rosales¹⁰^*, Alvaro Cabrero Garcia¹¹^*, Lauro Fabian Amador¹²^*, Carmina Alejandra Córdova-Ramírez¹³^*, Iván Murrieta-Álvarez¹³^*, Juan Carlos Solís-Poblano¹⁴^*, Elia Ixel Apodaca¹^*, Juan Rangel-Patiño, MD¹⁵, Jose Luis Álvarez¹⁶^*, Luara Arana, MD¹⁶, Jose Antonio De la Peña-Celaya¹⁶^*, María Eugenia Espitia¹⁶^*, Eleazar Hernandez, MD¹⁷^*, Juan Manuel Perez¹⁶^*, Rosa González-Rivera⁴^*, María Fernanda García-Leyva⁵^*, Estefania Peña³^*, Monica Tejeda Romero⁷^*, Carolina Balderas-Delgado¹¹^*, Jorge Cruz Rico⁷^*, Guillermo Ruiz Arguelles¹³^* and David Gomez-Almaguer, MD ⁸

¹Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico
²Centro Medico Nacional 20 de Noviembre, Mexico City, Mexico
³Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru
⁴Hospital de Especialidades, Centro Médico Nacional Siglo XXI, IMSS, Mexico City, Mexico
⁵Instituto Nacional de Cancerología, Mexico City, Mexico
⁶Complejo Hospitalario Doctor Arnulfo Arias Madrid, Panamá, Panama
⁷Hospital Juárez De México, Mexico City, Mexico
⁸Universidad Autonoma de Nuevo Leon, Hospital Universitario "Dr. José Eleuterio Gonzalez", Monterrey, Mexico
⁹Hospital General San Juan de Dios, Guatemala, Guatemala
¹⁰Instituto Guatemalteco de Seguridad Social, Guatemala, Guatemala
¹¹Hospital Regional de Alta Especialidad de Ixtapaluca, Estado de México, Mexico
¹²Hospital Regional de Alta Especialidad del Bajio, León, Mexico
¹³Centro de Hematología y Medicina Interna, Puebla, Mexico
¹⁴Hospital de Especialidades CMN “Manuel Ávila Camacho”, IMSS, Puebla, Mexico
¹⁵Department of Hematology and Oncology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico
¹⁶Centro Médico Nacional 20 de noviembre, ISSSTE, Mexico City, Mexico
¹⁷Centro Medico Nacional 20 de Noviembre, UNAM, Mexico City, Mexico

2:45 PM

747

Economic and Clinical Burden of Virus-Associated Hemorrhagic Cystitis in Patients Following Allogeneic Hematopoietic Stem Cell Transplantation

Joseph P. McGuirk, DO¹, Clint Divine, MBA, MSM¹^*, Seung Hyun Moon, MD, MPA²^*, Aastha Chandak, PhD³^*, Zhiji Zhang, MS³^* and Genovefa A. Papanicolaou, MD⁴^*

¹The University of Kansas Cancer Center, Westwood, KS
²AlloVir, Inc., Cambridge, MA
³Certara, New York, NY
⁴Department of Medicine, Infectious Disease, Memorial Sloan Kettering Cancer Center, New York, NY

See more of: Oral and Poster Abstracts

<< Previous Session | Next Session >>

^*signifies non-member of ASH

902.O1.6 902. Health Services Research—Malignant Conditions (Lymphoid Disease) II